These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
802 related items for PubMed ID: 23993668
41. Synthesis and structure-activity relationships of 5-phenyloxazole-2-carboxylic acid derivatives as novel inhibitors of tubulin polymerization. Zhang R, Mo H, Ma YY, Zhao DG, Zhang K, Zhang T, Chen X, Zheng X. Bioorg Med Chem Lett; 2021 May 15; 40():127968. PubMed ID: 33753264 [Abstract] [Full Text] [Related]
42. Biological evaluation and molecular modelling study of podophyllotoxin derivatives as potent inhibitors of tubulin polymerization. Ma Y, Fang S, Li H, Han C, Lu Y, Zhao Y, Liu Y, Zhao C. Chem Biol Drug Des; 2013 Jul 15; 82(1):12-21. PubMed ID: 23786349 [Abstract] [Full Text] [Related]
43. Design and bio-evaluation of novel millepachine derivatives targeting tubulin colchicine binding site for treatment of osteosarcoma. Geng D, Chen Z, Li Y, Liu T, Wang L. Bioorg Chem; 2024 Oct 15; 151():107624. PubMed ID: 39002514 [Abstract] [Full Text] [Related]
44. Synthesis and biological evaluation of imidazopyridine-oxindole conjugates as microtubule-targeting agents. Kamal A, Reddy VS, Karnewar S, Chourasiya SS, Shaik AB, Kumar GB, Kishor C, Reddy MK, Narasimha Rao MP, Nagabhushana A, Ramakrishna KV, Addlagatta A, Kotamraju S. ChemMedChem; 2013 Dec 15; 8(12):2015-25. PubMed ID: 24115733 [Abstract] [Full Text] [Related]
49. Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin. Kim DY, Kim KH, Kim ND, Lee KY, Han CK, Yoon JH, Moon SK, Lee SS, Seong BL. J Med Chem; 2006 Sep 21; 49(19):5664-70. PubMed ID: 16970393 [Abstract] [Full Text] [Related]
50. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents. Hu Y, Lu X, Chen K, Yan R, Li QS, Zhu HL. Bioorg Med Chem; 2012 Jan 15; 20(2):903-9. PubMed ID: 22192936 [Abstract] [Full Text] [Related]
52. Synthesis and biological evaluation of 2,4,5-substituted pyrimidines as a new class of tubulin polymerization inhibitors. Xie F, Zhao H, Li D, Chen H, Quan H, Shi X, Lou L, Hu Y. J Med Chem; 2011 May 12; 54(9):3200-5. PubMed ID: 21480626 [Abstract] [Full Text] [Related]
53. Synthesis and biological evaluation of 1-benzylidene-3,4-dihydronaphthalen-2-one as a new class of microtubule-targeting agents. Liu J, Zheng CH, Ren XH, Zhou F, Li W, Zhu J, Lv JG, Zhou YJ. J Med Chem; 2012 Jun 28; 55(12):5720-33. PubMed ID: 22676247 [Abstract] [Full Text] [Related]
54. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors. Cao D, Liu Y, Yan W, Wang C, Bai P, Wang T, Tang M, Wang X, Yang Z, Ma B, Ma L, Lei L, Wang F, Xu B, Zhou Y, Yang T, Chen L. J Med Chem; 2016 Jun 23; 59(12):5721-39. PubMed ID: 27213819 [Abstract] [Full Text] [Related]
55. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities. Sun YX, Song J, Kong LJ, Sha BB, Tian XY, Liu XJ, Hu T, Chen P, Zhang SY. Eur J Med Chem; 2022 Feb 05; 229():114069. PubMed ID: 34971875 [Abstract] [Full Text] [Related]